Catalyst Wire Dossier Catalyst Wire Dossier

NANT Merkel Cell Carcinoma (MCC) Vaccine

· ImmunityBio, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NANT Merkel Cell Carcinoma (MCC) Vaccine, covering 2025-02-21 to 2025-02-21. Get the full timeline:

Most recent: Clinical Trial Update: QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 Therapy [Phase 1, Phase 2]

See pricing